Aterian Opportunities II
Managed by Aterian Investment Partners
Overview
Aterian Opportunities II is a single-asset continuation vehicle established to acquire Vander-Bend Manufacturing from an earlier Aterian fund. Vander-Bend now operates as Vantedge Medical, a MedTech manufacturer serving markets including robotic-assisted surgery and radiation oncology.
Aterian Investment Partners is a middle-market private equity firm founded in 2009. The firm invests alongside management teams and supports portfolio companies through strategic positioning and operational areas including people, processes, equipment, technology and product innovation. Aterian has a preference for control investments in U.S. and Canadian businesses. Its approach includes family- and founder-owned companies, corporate carve-outs and complex situations, with an emphasis on buy-and-build and operational improvement where relevant.
Selected investments
- Vantedge Medical — The fund owns Vantedge Medical, formerly Vander-Bend Manufacturing. The company provides precision manufacturing and assembly, engineering, prototyping, and quality-system services to medical technology customers.
Acquire an interest in Aterian Opportunities II
You might be able to acquire a position in Aterian Opportunities II. Sign up to explore available positions.
Gauge buyer interest for Aterian Opportunities II
Sign up here to anonymously gauge interest in your Aterian Opportunities II position.
Do you manage this fund? Get in touch to edit the text here.